UNMC_Acronym_Vert_sm_4c
University of Nebraska Medical Center

Research

DEM Research 2020

Our faculty work with patients involved in clinical trials related to diabetes, endocrinology and metabolism. Find clinical trials by prinicipal investigor listed below.

Learn how you can participate in UNMC clinical trials.

Faculty Research Interests

Laura Armas, MD

Laura Armas, MD

Dr. Armas has a research interest in calcium and vitamin D and is currently working on an NIH-funded grant in collaboration with Creighton focusing on the effects of T1DM on bone in postmenopausal women.

Robert Bennett, PhD

Robert G. Bennett, PhD

Relaxin in adipose function and fibrosis Targeted treatment of the liver-adipose axis in metabolic diseases

Brian Boerner, MD

Brian Boerner, MD

Inpatient management of hyperglycemia in transplant recipients Medical Education

Cyrus V. Desouza, MBBS

Cyrus V. Desouza, MBBS

Dr. Desouza works in cardiovascular disease outcomes research in diabetes, focusing on why people with diabetes have heart attacks and strokes and how can they be treated. He is principal investigator of numerous UNM clinical trials. He also conducts research into how to improve diabetes care and diabetes outcomes in settings such as the VA system, rural areas and others.

Dr. Desouza's clinical trials

Andjela Drincic, MD

Andjela Drincic, MD

Type 1 diabetes and neurosciences Pituitary including (growth hormone, Cushing’s, acromegaly)

Dr. Drincic's clinical trials

Leslie Eiland, MD

Leslie Eiland, MD

Dr. Eiland's primary research interests involve telehealth and diabetes technology. She has shown successful outcomes regarding management of people with type 1 diabetes seen in rural telehealth clinics. Current projects involve analyzing access to care and telehealth utilization for people during the COVID-19 pandemic, as well as understanding people’s experiences and preferences around different types of telehealth visits.

Whitney S. Goldner, MD

Whitney S. Goldner, MD

Dr. Goldner conducts clinical research on thyroid nodules and thyroid cancer. She has an interest in molecular testing of thyroid nodules, as well as thyroid cancer treatments and outcomes; and in environmental exposures and thyroid disease and thyroid cancer.

Dr. Goldner's clinical trials

Frederick G. Hamel, PhD

Role of insulin-degrading enzyme in insulin action and development of insulin resistance Signal transduction mechanisms of peptide hormones, especially insulin Biologic activity of insulin degradation products Role of insulin degrading enzyme in the pathophysiology of diabetes. Role of insulin degrading enzyme in insulin resistance caused by protease inhibitors Etiology of type 2 diabetes mellitus

Anupam Kotwal, MD

Anupam Kotwal, MD

Dr. Kotwal conducts multidisciplinary translational research to identify prognostic immune biomarkers (via multiplex immunofluorescence, RNA sequencing and flow cytometry) for thyroid cancer and evaluate their association with the differential clustering of thyroid cancer in Nebraska related to social, demographic and environmental factors. He also studies endocrine dysfunction caused by novel immunotherapies used to treat various cancers and has demonstrated that the occurrence of thyroid dysfunction from these therapies is a biomarker for improved survival.

Jennifer L. Larsen, MD

Jennifer L. Larsen, MD

Dr. Larsen conducts research into nontraditional risk factors for vascular disease after kidney transplant; primary prevention of diabetes and its complications; and improving outcomes after solid organ transplant.

Lynn R. Mack, MD

Lynn R. Mack, MD

Dr. Mack's research interests are related to bone health with an interest in bone loss in cystic fibrosis and bone loss with short bowel syndrome.

Vijay Shivaswamy, MBBS

Vijay Shivaswamy, MBBS

Cardiovascular outcome clinical trials in diabetes

Dr. Shivaswamy's clinical trials

Saraswathi Viswanathan, PhD

The role of adipose tissue inflammation in mediating obesity-linked metabolic disorders The role of oxidative stress and inflammation on alcoholic liver injury in obesity Altered amino acid metabolism in pancreatic cancer